Clinical Trial Update: Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bevacizumab with fluorouracil and external-beam radiation therapy in patients with stage II or stage III rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Rectum, Stage II Rectal Cancer | Phase 1 | Status: COMPLETED